SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-17-019440
Filing Date
2017-03-28
Accepted
2017-03-27 17:58:22
Documents
1
Effectiveness Date
2017-03-28

Document Format Files

Seq Description Document Type Size
1 DEFA14A a17-2335_12defa14a.htm DEFA14A 26734
  Complete submission text file 0001104659-17-019440.txt   27941
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-30319 | Film No.: 17716344
SIC: 2834 Pharmaceutical Preparations